Capri Holdings Limited enters the second quarter of Fiscal 2027 as a fundamentally different company from the one investors knew a year ago. The British Virgin Islands-domiciled holding company completed the sale of Versace to Prada S.p.A. in late 2025, and immediately redirected the proceeds toward debt reduction, capital returns, and brand reinvestment. The strategic reset is visible in the quarterly numbers. Net debt fell from roughly $1.5 billion a year ago to $224 million. Operating cash flow from continuing operations nearly quadrupled versus the prior-year period. The repositioning is structural rather than tactical, reflecting an explicit strategy to focus capital and management attention on the two highest-return brand platforms after the failed 2024 merger and the successful 2025 divestiture.
The first-quarter operating results themselves were mixed by brand but constructive in aggregate. Total revenue declined 3.5% on a reported basis and 4.1% in constant currency against a difficult comparison. Reported gross margin expanded 200 basis points. Adjusted operating margin reached 3.6% versus 2.5% in the prior-year period. The lift came primarily from disciplined full-price selling at Michael Kors and lower effective tariff costs following the favorable IEEPA ruling. Diluted earnings per share of $0.60 and adjusted diluted EPS of $0.67 both exceeded prior expectations. Management reiterated full-year EPS guidance of approximately $2.15, signaling confidence in the margin trajectory even as the revenue outlook softened across the second quarter and the full year.
The investment narrative now hinges on whether Michael Kors can stabilize its Americas and EMEA comparable store trends while Jimmy Choo sustains double-digit reported growth and progresses toward consistent segment-level profitability. With shares trading near $13.24 against a fifty-two week range that has compressed sharply from the prior peak, the equity sits at a discount to historical luxury multiples. The price discount reflects the post-divestiture profile, the discretionary consumer overhang, and the tariff backdrop. Market capitalization sits around $1.52 billion. Market capitalization sits around $1.52 billion, with roughly $871 million remaining under the buyback authorization. The investor debate is execution credibility rather than brand quality, and the next two quarterly prints carry meaningful weight in resolving the debate. Patient capital is best positioned for the setup. The combination of brand strength, balance sheet repair, and active capital return creates an asymmetric payoff profile that rewards multi-quarter holding periods and tolerates interim volatility around tariff, currency, and consumer headlines.